Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Ortho-tag Inc.

Making orthopedic implants smart

This article was originally published in Start Up

Executive Summary

There are times when joint replacement patients and their treating physicians need to quickly identify what kind of orthopedic device has been implanted, but the information isn’t always easy to find. Ortho-tag Inc. aims to change that with a tag that turns orthopedic implants into devices capable of communicating important information to treating physicians directly from the patient.

You may also be interested in...



UDI Final Rule Listed For July Release In HHS Regulatory Agenda

The UDI final rule is among 11 device-focused proposed and final regulations included in the HHS unified agenda of regulations planned through early 2014, and it is likely the most closely watched of the group by industry.

Data Questions Dominate Metal-On-Metal Panel; New Monitoring Recommended

FDA advisory panel examines science behind controversial metal-on-metal hips, recommends new monitoring, possible label changes.

Parkinson’s Results Further Sweeten AbbVie’s Acquisition of Cerevel

Cerevel, which AbbVie is spending $8.7bn to acquire, unveiled topline results from the TEMPO-3 study of tavapadon, which an analyst said represents potentially a $1bn opportunity.

Topics

Related Companies

Latest Headlines
See All
UsernamePublicRestriction

Register

MT037907

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel